A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia

Abstract

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAA multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.Initially, six HTA panels (pharmaceuticals, acute sector, primary and community care, diagnostics and imaging, population screening, methodology) helped to set the research priorities for the HTA Programme. However, during the past few years there have been a number of changes in and around NHS R&D, such as the establishment of the National Institute for Clinical Excellence (NICE) and the creation of three new research programmes: Service Delivery and Organisation (SDO); New and Emerging Applications of Technology (NEAT); and the Methodology Programme.This has meant that the HTA panels can now focus more explicitly on health technologies ('health technologies' are broadly defined to include all interventions used to promote heal...

Decision Coaching to Prepare Patients for Making Health Decisions

“…26 In addition to the PtDA plus decision coaching having lower mean costs, there was a higher number of quality-adjusted life years using the EQ-5D instrument (1.582 v. 1.567) indicating that it was more cost-effective compared with PtDA alone. 30 However, this trial reported no difference in health outcomes between groups using the SF-36. One trial that measured anxiety and depression found no difference in those exposed to coaching plus a PtDA compared with a PtDA alone.…”

“…24 This trial reported that couples were more satisfied with coaching but had no difference in knowledge (because similar information was provided to both groups), decisional conflict, uptake of prenatal screening, or pregnancy outcomes. Two other trials compared coaching interventions that included explicit values clarification to PtDA without explicit values clarification and reported the combined intervention was more cost-effective, 26,30 improved values-choice agreement, and decreased decisional conflict. 17 …”

Evaluation of an informed choice invitation for type 2 diabetes screening

“…However, whilst the psychological effects of screening do appear to be minimal, there are burdens associated with diagnosis following screen detection [9,10]. It is possible that information about the type and likelihood of the burdens associated with the screening procedure as well as the possible treatment, when presented alongside the type and likelihood of the benefits, could deter some people from participating in screening programmes [11][12][13][14].…”

The cost-effectiveness of patient decision aids: A systematic review

“…This three-arm randomized trial was described in two separate articles. 14,15 It investigated the use of a PtDA with and without a nurse interview, in women with menorrhagia, compared to usual care. They found that the PtDA plus interview strategy was dominant, by incurring lower costs (d1030) and higher QALYs (1.582) compared to the PtDA alone (d1333, 1.567) or usual care (d1810, 1.574).…”